Robby Markwart

2.2k total citations · 2 hit papers
32 papers, 1.5k citations indexed

About

Robby Markwart is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Robby Markwart has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Applied Microbiology and Biotechnology. Recurrent topics in Robby Markwart's work include Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Robby Markwart is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Antibiotic Resistance in Bacteria (5 papers). Robby Markwart collaborates with scholars based in Germany, United Kingdom and Sweden. Robby Markwart's co-authors include Tim Eckmanns, Olaniyi Ayobami, Niklas Willrich, Thomas Harder, Felix Reichert, Benedetta Allegranzi, Carolin Fleischmann-Struzek, Alessandro Cassini, Ignacio Rubio and Annicka Reuß and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Robby Markwart

31 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis

2021 237 citations Carolin Fleischmann-Struzek, Felix Reichert et al. Archives of Disease in Childhood profile →
Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis

2020 223 citations Robby Markwart, Thomas Harder et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robby Markwart Germany	19	423	344	322	274	249	32	1.5k
Francisco Javier Candel Spain	22	677 1.6×	253 0.7×	260 0.8×	540 2.0×	194 0.8×	162	1.7k
Mao Hagihara Japan	28	675 1.6×	534 1.6×	336 1.0×	712 2.6×	170 0.7×	168	2.3k
Michael Osthoff Switzerland	21	430 1.0×	196 0.6×	183 0.6×	317 1.2×	122 0.5×	94	1.6k
Yuka Yamagishi Japan	24	871 2.1×	390 1.1×	293 0.9×	752 2.7×	235 0.9×	213	2.3k
Jeffrey R. Strich United States	19	589 1.4×	218 0.6×	264 0.8×	510 1.9×	138 0.6×	44	1.5k
Sébastien Tanaka France	27	677 1.6×	286 0.8×	616 1.9×	487 1.8×	111 0.4×	69	2.1k
Stefan Hagel Germany	22	753 1.8×	190 0.6×	227 0.7×	691 2.5×	193 0.8×	125	1.9k
Francisc Schlaeffer Israel	24	735 1.7×	197 0.6×	527 1.6×	429 1.6×	226 0.9×	80	2.0k
Jin‐Yong Jeong South Korea	24	529 1.3×	286 0.8×	281 0.9×	447 1.6×	124 0.5×	47	1.4k
Jerina Boelens Belgium	20	734 1.7×	279 0.8×	181 0.6×	487 1.8×	92 0.4×	83	1.8k

Countries citing papers authored by Robby Markwart

Since Specialization

Citations

This map shows the geographic impact of Robby Markwart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robby Markwart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robby Markwart more than expected).

Fields of papers citing papers by Robby Markwart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robby Markwart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robby Markwart. The network helps show where Robby Markwart may publish in the future.

Co-authorship network of co-authors of Robby Markwart

This figure shows the co-authorship network connecting the top 25 collaborators of Robby Markwart. A scholar is included among the top collaborators of Robby Markwart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robby Markwart. Robby Markwart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bleidorn, Jutta, et al.. (2025). The Impact of Point-of-Care Testing for Group A Streptococcal Pharyngitis on Antibiotic Prescribing and Patient Health Outcomes in Outpatient Care: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Open Forum Infectious Diseases. 12(7). ofaf407–ofaf407.

Markwart, Robby, et al.. (2024). Utilisation and consequences of CRP point-of-care-testing in primary care practices: a real-world multicentre observational study with 1740 patient cases in Germany. BJGP Open. 9(1). BJGPO.2024.0120–BJGPO.2024.0120. 2 indexed citations

Markwart, Robby, et al.. (2024). Utilisation and trends of laboratory testing and point-of-care testing in primary care in Germany: an analysis of claims data. BMJ Open. 14(12). e093780–e093780. 1 indexed citations

Wolf, Florian, et al.. (2023). Point-of-care measurement of C-reactive protein promotes de-escalation of treatment decisions and strengthens the perceived clinical confidence of physicians in out-of-hours outpatient emergency medical services. BMJ Open. 13(5). e069453–e069453. 5 indexed citations

Ayobami, Olaniyi, et al.. (2022). Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis. Emerging Microbes & Infections. 11(1). 443–451. 106 indexed citations

Bleidorn, Jutta, et al.. (2022). Research on point-of-care tests in outpatient care in Germany: A scoping review and definition of relevant endpoints in evaluation studies. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 174. 1–10. 5 indexed citations

Willrich, Niklas, et al.. (2021). The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): an analysis of data from the national Antimicrobial Resistance Surveillance system. Antimicrobial Resistance and Infection Control. 10(1). 45–45. 29 indexed citations

Reuß, Annicka, Niklas Willrich, Marcel Feig, et al.. (2021). Antimicrobial Resistance and the Spectrum of Pathogens in Dental and Oral-Maxillofacial Infections in Hospitals and Dental Practices in Germany. Frontiers in Microbiology. 12. 676108–676108. 37 indexed citations

Markwart, Robby, Niklas Willrich, Tim Eckmanns, Guido Werner, & Olaniyi Ayobami. (2021). Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe. Frontiers in Microbiology. 12. 664199–664199. 26 indexed citations

10.

Fleischmann-Struzek, Carolin, Felix Reichert, Alessandro Cassini, et al.. (2021). Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Archives of Disease in Childhood. 106(8). 745–752. 237 indexed citations breakdown →

11.

Ayobami, Olaniyi, et al.. (2020). The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017. Antimicrobial Resistance and Infection Control. 9(1). 89–89. 48 indexed citations

12.

Ayobami, Olaniyi, Niklas Willrich, Annicka Reuß, Tim Eckmanns, & Robby Markwart. (2020). The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerging Microbes & Infections. 9(1). 1180–1193. 103 indexed citations

13.

Ayobami, Olaniyi, Niklas Willrich, Thomas Harder, et al.. (2019). The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis. Emerging Microbes & Infections. 8(1). 1747–1759. 121 indexed citations

14.

Markwart, Robby, Niklas Willrich, Sebastian Haller, et al.. (2019). The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS). Antimicrobial Resistance and Infection Control. 8(1). 147–147. 88 indexed citations

15.

Geißler, Katharina, Robby Markwart, Robert Pascal Requardt, et al.. (2017). Functional characterization of T-cells from palatine tonsils in patients with chronic tonsillitis. PLoS ONE. 12(9). e0183214–e0183214. 19 indexed citations

16.

Galler, Kerstin M., Robert Pascal Requardt, U. Gläser, et al.. (2016). Single cell analysis in native tissue: Quantification of the retinoid content of hepatic stellate cells. Scientific Reports. 6(1). 24155–24155. 19 indexed citations

17.

Hennig, Anne K., Robby Markwart, Katharina Wolff, et al.. (2016). Feedback activation of neurofibromin terminates growth factor-induced Ras activation. Cell Communication and Signaling. 14(1). 5–5. 28 indexed citations

18.

Weigel, Cynthia, Katharina Geißler, Robby Markwart, et al.. (2015). Isolation of viable and functional T-cells from human palatine tonsils. Journal of Immunological Methods. 427. 66–72. 7 indexed citations

19.

Jung, Maximilian, Lars Björn Riecken, Tobias Sperka, et al.. (2013). Regulation of Son of sevenless by the membrane-actin linker protein ezrin. Proceedings of the National Academy of Sciences. 110(51). 20587–20592. 20 indexed citations

20.

Hennig, Anne K., Katja Schubert, Robby Markwart, et al.. (2013). Ras palmitoylation is necessary for N-Ras activation and signal propagation in growth factor signalling. Biochemical Journal. 454(2). 323–332. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact